[Use of a new association trimethoprime-sulfamethoxazole in urinary infections in gyneco-obstetrics].
D000031:Abortion, Septic / Q000188:drug therapy; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D005831:Genital Diseases, Female / Q000188:drug therapy*; D006801:Humans; D011247:Pregnancy; D011645:Puerperal Infection / Q000188:drug therapy; D011743:Pyrimidines / Q000627:therapeutic use*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Utilisation d'une nouvelle association triméthoprime-sulfaméthoxazole dans les infections urinaires en gynécologie-obstétrique.